Prof. Dr. Giovanni Zucchelli: Clinical case solved with a coronally advanced flap together with Straumann® Emdogain® and botiss mucoderm®
Esthetics are becoming increasingly important and with this trend, the request for root coverage procedures.
Esthetics are becoming increasingly important and with this trend, the request for root coverage procedures.
Although it has been shown that adding Straumann® Emdogain® to a coronally advanced flap (CAF) procedure leads to clinical results after one and after ten years comparable to a CAF procedure with an autologous connective tissue graft1 , the addition of a connective tissue graft is still recommended when treating patients with a thin gingival biotype2 . Tissue harvesting is associated with patient discomfort and a higher risk for post-operative complications. The combined application of Straumann® Emdogain® and botiss mucoderm® is a valid alternative to autologous tissue grafts3.
Straumann® Emdogain® is a unique gel containing enamel matrix derivative of porcine origin. The main component is amelogenin, which has demonstrated the ability to stimulate certain cells types involved in the healing process of soft and hard tissues towards a regenerative pattern, thus leading to true periodontal regeneration and accelerated oral wound healing. In root coverage procedures, using Straumann® Emdogain® leads to:
botiss mucoderm® provides a true alternative to the patient’s connective tissue graft in certain indications (recession coverage Miller class I-III 10-12, broadening of attached gingiva13, soft tissue augmentation/thickening14-17). This stable 3-dimensional collagen soft tissue replacement, made of porcine dermis, supports fast revascularization and soft tissue integration, including color and texture. As an alternative to autologous tissue grafts, using botiss mucoderm® leads to: